<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
	<id>https://www.cleauxfees.org/mediawiki/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=BellaSloane344</id>
	<title>Les Pèlerins de Torus - Contributions [fr]</title>
	<link rel="self" type="application/atom+xml" href="https://www.cleauxfees.org/mediawiki/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=BellaSloane344"/>
	<link rel="alternate" type="text/html" href="https://www.cleauxfees.org/mediawiki/index.php?title=Sp%C3%A9cial:Contributions/BellaSloane344"/>
	<updated>2026-07-23T20:15:36Z</updated>
	<subtitle>Contributions</subtitle>
	<generator>MediaWiki 1.39.2</generator>
	<entry>
		<id>https://www.cleauxfees.org/mediawiki/index.php?title=Fildena:_A_Comprehensive_Report_On_The_Sildenafil-Based_Erectile_Dysfunction_Medication&amp;diff=12924</id>
		<title>Fildena: A Comprehensive Report On The Sildenafil-Based Erectile Dysfunction Medication</title>
		<link rel="alternate" type="text/html" href="https://www.cleauxfees.org/mediawiki/index.php?title=Fildena:_A_Comprehensive_Report_On_The_Sildenafil-Based_Erectile_Dysfunction_Medication&amp;diff=12924"/>
		<updated>2026-07-14T13:25:17Z</updated>

		<summary type="html">&lt;p&gt;BellaSloane344 : Page créée avec « &amp;lt;br&amp;gt;Fildena is a widely recognized pharmaceutical product used for the treatment of erectile dysfunction (ED) in men. Manufactured by Fortune Healthcare, an Indian pharmaceutical company, Fildena contains the active ingredient sildenafil citrate, the same compound found in the brand-name drug Viagra. Since its introduction, Fildena has gained popularity due to its efficacy, affordability, and variety of dosage strengths. This report provides a detailed overview o... »&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;br&amp;gt;Fildena is a widely recognized pharmaceutical product used for the treatment of erectile dysfunction (ED) in men. Manufactured by Fortune Healthcare, an Indian pharmaceutical company, Fildena contains the active ingredient sildenafil citrate, the same compound found in the brand-name drug Viagra. Since its introduction, Fildena has gained popularity due to its efficacy, affordability, and variety of dosage strengths. This report provides a detailed overview of Fildena, including its mechanism of action, therapeutic uses, dosage forms, side effects, contraindications, and safety considerations.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Mechanism of Action&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Fildena works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which is primarily found in the smooth muscle of the corpus cavernosum in the penis. Under normal physiological conditions, sexual stimulation triggers the release of nitric oxide, which activates guanylate cyclase and increases cyclic guanosine monophosphate (cGMP) levels. cGMP causes relaxation of smooth muscle, allowing increased blood flow into the penis, leading to an erection. PDE5 breaks down cGMP, terminating the erectile response. By blocking PDE5, Fildena preserves cGMP levels, thereby enhancing and prolonging erections in response to sexual arousal. It is important to note that Fildena does not cause erections without sexual stimulation; it only facilitates the natural process.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Therapeutic Uses&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The primary indication for Fildena is erectile dysfunction, defined as the consistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It is effective in men of various ages and etiologies,  Help &amp;amp; FAQ ([http://Smashclub.es/ http://Smashclub.es/]) including those with organic, psychogenic, or mixed causes. Additionally, Fildena has been used off-label for the treatment of pulmonary arterial hypertension (PAH) under the brand name Revatio, though the dosage for PAH is much lower (20 mg three times daily) compared to ED doses. However, this report focuses on its use for ED.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Dosage Forms and Strengths&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Fildena is available in several strengths: 25 mg, 50 mg, 100 mg, 120 mg, 150 mg, and 200 mg. The most commonly prescribed starting dose is 50 mg, taken approximately 30–60 minutes before sexual activity. The dose can be adjusted based on efficacy and tolerability. The maximum recommended frequency is once per day. The 200 mg strength is typically reserved for men who have not responded adequately to lower doses. Fildena also comes in different formulations, such as chewable tablets (Fildena Chewable), sublingual tablets, and oral jelly (Fildena XXX) for faster absorption. The oral jelly is particularly useful for men who have difficulty swallowing pills.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Efficacy and Clinical Studies&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Clinical trials have demonstrated that sildenafil significantly improves erectile function compared to placebo. In a pooled analysis, approximately 70–80% of men with ED reported improved erections with sildenafil, compared to 20–30% with placebo. The onset of action is about 30–60 minutes, but it may be delayed if taken with a high-fat meal. The duration of effect is typically 4–6 hours, though some men may experience responsiveness for up to 12 hours. Efficacy is maintained with [https://pixabay.com/images/search/long-term/ long-term] use.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Side Effects&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Like all medications, Fildena can cause side effects. The most common are headache, flushing, dyspepsia, nasal congestion, dizziness, and visual disturbances (e.g., blue-tinged vision, sensitivity to light). These effects are usually mild to moderate and transient. Serious adverse events are rare but include priapism (prolonged, painful erection lasting more than 4 hours), sudden hearing loss, and cardiovascular events such as myocardial infarction or stroke. The risk of cardiovascular events is higher in men with pre-existing heart conditions, especially those who engage in sexual activity after taking Fildena. Sudden vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION) has been reported, though a direct causal link is not established.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Contraindications and Precautions&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Fildena should not be taken by men who are using nitrates (e.g., nitroglycerin, isosorbide mononitrate) for chest pain, as the combination can cause a severe drop in blood pressure. It is also contraindicated in men with severe hepatic impairment, hypotension (blood pressure &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Drug Interactions&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Fildena interacts with several medications. Apart from nitrates, it can potentiate the hypotensive effects of alpha-blockers (used for hypertension or benign prostatic hyperplasia). Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, erythromycin) can significantly increase sildenafil plasma concentrations, requiring dose reduction. Conversely, CYP3A4 inducers (e.g., rifampin) may reduce efficacy.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Safety in Special Populations&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Fildena is not indicated for use in women or children. In elderly men (≥65 years), lower starting doses (25 mg) may be considered due to increased sensitivity and reduced clearance. Men with renal or hepatic impairment should also start with a low dose. The medication is classified as pregnancy category B (for sildenafil) but is not used in women.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Manufacturer and Quality Control&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Fortune Healthcare is an ISO-certified manufacturer that adheres to Good Manufacturing Practices (GMP). Fildena is produced in facilities approved by the Indian drug regulatory authority. While generic sildenafil from Indian manufacturers is widely used globally, it is important to purchase from reputable sources to ensure quality and avoid counterfeit products.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Conclusion&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Fildena is an effective and cost-efficient option for the management of [https://soundcloud.com/search/sounds?q=erectile%20dysfunction&amp;amp;filter.license=to_modify_commercially erectile dysfunction]. With multiple dosage forms and strengths, it offers flexibility to meet individual patient needs. However, as with any medication, it should be used under medical supervision. Patients should be screened for cardiovascular risk and advised about potential side effects and interactions. Despite its safety profile, self-medication without a prescription is discouraged. Overall, Fildena represents a valuable therapeutic tool that has helped millions of men improve their sexual health and quality of life.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>BellaSloane344</name></author>
	</entry>
	<entry>
		<id>https://www.cleauxfees.org/mediawiki/index.php?title=Cefixime:_A_Comprehensive_Overview_Of_A_Third-Generation_Cephalosporin_Antibiotic&amp;diff=12892</id>
		<title>Cefixime: A Comprehensive Overview Of A Third-Generation Cephalosporin Antibiotic</title>
		<link rel="alternate" type="text/html" href="https://www.cleauxfees.org/mediawiki/index.php?title=Cefixime:_A_Comprehensive_Overview_Of_A_Third-Generation_Cephalosporin_Antibiotic&amp;diff=12892"/>
		<updated>2026-07-14T12:44:54Z</updated>

		<summary type="html">&lt;p&gt;BellaSloane344 : Page créée avec « &amp;lt;br&amp;gt;Cefixime is a broad-spectrum, third-generation cephalosporin antibiotic that has been a cornerstone in the management of various bacterial infections since its introduction in the late 1980s. It is an orally administered agent, distinguished by its enhanced activity against gram-negative [https://search.un.org/results.php?query=bacteria%20compared bacteria compared] to earlier generations of cephalosporins, while retaining useful activity against many gram-po... »&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;br&amp;gt;Cefixime is a broad-spectrum, third-generation cephalosporin antibiotic that has been a cornerstone in the management of various bacterial infections since its introduction in the late 1980s. It is an orally administered agent, distinguished by its enhanced activity against gram-negative [https://search.un.org/results.php?query=bacteria%20compared bacteria compared] to earlier generations of cephalosporins, while retaining useful activity against many gram-positive organisms. Its unique pharmacokinetic profile, stability against certain beta-lactamases, and convenient dosing schedule have made it a popular choice in both hospital and community settings. This report provides a detailed examination of cefixime, covering its mechanism of action, antimicrobial spectrum, pharmacokinetics, clinical indications, adverse effects, resistance patterns, and current role in therapy.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Mechanism of Action&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Like all beta-lactam antibiotics, cefixime exerts its bactericidal effect by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), which are enzymes responsible for cross-linking the peptidoglycan chains that form the rigid cell wall structure. By acylating the active site of PBPs, cefixime prevents the final transpeptidation step, leading to a weakened cell wall that cannot withstand osmotic pressure. This results in cell lysis and death, particularly in actively dividing bacteria. Cefixime has high affinity for PBPs of gram-negative organisms such as Escherichia coli and Neisseria gonorrhoeae, which accounts for its potent activity against these pathogens.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Antimicrobial Spectrum&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Cefixime exhibits a broad spectrum of activity, with notable efficacy against a range of gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Haemophilus influenzae, Moraxella catarrhalis, and Neisseria gonorrhoeae. It is also active against some gram-positive organisms such as Streptococcus pyogenes and Streptococcus pneumoniae, though it is not effective against methicillin-resistant Staphylococcus aureus (MRSA) or Enterococcus species. Importantly, cefixime is stable in the presence of many beta-lactamases produced by gram-negative bacteria, including TEM-1 and SHV-1, but it can be hydrolyzed by extended-spectrum beta-lactamases (ESBLs) and AmpC beta-lactamases. This instability limits its utility against ESBL-producing organisms, which are increasingly prevalent.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Pharmacokinetics&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Cefixime is administered orally, with bioavailability of approximately 40–50%. It is available as tablets, capsules, and oral suspension. The drug is absorbed primarily in the upper gastrointestinal tract, and food does not significantly affect absorption, though it may slightly delay the peak concentration. Peak serum concentrations are reached about 2–6 hours after dosing. Cefixime has a relatively long elimination half-life of 3–4 hours, allowing for once-daily or twice-daily dosing. It is highly protein-bound (approximately 65%) and is excreted largely unchanged in the urine via glomerular filtration and tubular secretion. Therefore, dose adjustment is required in patients with significant renal impairment (creatinine clearance &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Clinical Indications&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Cefixime is approved for the treatment of a variety of infections, including uncomplicated urinary tract infections (UTIs) caused by susceptible gram-negative bacteria, otitis media, pharyngitis and tonsillitis due to S. pyogenes, acute exacerbations of chronic bronchitis, community-acquired pneumonia, and uncomplicated gonorrhea. In pediatric populations, it is commonly used for otitis media and  [http://stefanodevecchi.it/cialis/ stefanodevecchi.it] - streptococcal pharyngitis. However, its use has declined in some areas due to increasing resistance, particularly among N. gonorrhoeae. The US Centers for Disease Control and Prevention (CDC) no longer recommends cefixime as first-line monotherapy for gonorrhea because of rising minimum inhibitory concentrations (MICs); instead, combination [https://www.medcheck-up.com/?s=therapy therapy] with azithromycin or ceftriaxone is preferred. Despite this, cefixime remains an option for uncomplicated gonococcal infections when ceftriaxone cannot be used, provided the isolate is susceptible.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Adverse Effects&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Cefixime is generally well tolerated. The most common adverse effects involve the gastrointestinal tract, including diarrhea (which may be loose stools or frank diarrhea), nausea, vomiting, and abdominal pain. The incidence of diarrhea is approximately 10–15%, and it is often mild and self-limiting. Cefixime can also cause hypersensitivity reactions ranging from mild skin rashes to rare but serious events such as Stevens-Johnson syndrome, angioedema, and anaphylaxis. Cross-allergenicity with penicillins exists, and caution is advised in patients with a history of immediate-type hypersensitivity to penicillins. Other adverse effects include headache, dizziness, eosinophilia, transient elevations in liver enzymes, and Clostridioides difficile-associated diarrhea (CDAD). Pseudomembranous colitis has been reported with use of nearly all antibacterial agents, including cefixime.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Resistance&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Resistance to cefixime has emerged as a significant clinical problem, particularly in Neisseria gonorrhoeae. Resistance mechanisms include the production of beta-lactamases (e.g., TEM-1, ROB-1) that hydrolyze the drug, alteration of PBPs (especially PBP2) reducing binding affinity, and decreased drug accumulation due to efflux pumps or porin mutations. In gram-negative enteric bacteria, resistance is often mediated by ESBLs (e.g., CTX-M types) and plasmid-mediated AmpC beta-lactamases, which can hydrolyze cefixime. The increasing prevalence of multidrug-resistant organisms has limited the empirical use of cefixime for serious infections, and susceptibility testing is recommended before therapy.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Dosage and Administration&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Standard dosing for adults is 400 mg daily either as a single dose or divided into 200 mg every 12 hours. For children, the dose is 8 mg/kg/day (up to 400 mg) given once daily or in two divided doses. In uncomplicated gonorrhea, a single 400 mg oral dose was historically used, but current guidelines prefer injectable ceftriaxone due to resistance concerns. For patients with renal impairment, dose reduction is necessary: if creatinine clearance is 10–30 mL/min, the recommended dose is 300 mg once daily; if less than 10 mL/min, 200 mg once daily. Cefixime is not significantly removed by hemodialysis.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Drug Interactions&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Cefixime has few clinically significant drug interactions. Probenecid can reduce renal excretion of cefixime, leading to increased serum levels. Anticoagulants like warfarin may have enhanced effects due to alterations in gut flora and vitamin K synthesis; monitoring of INR is recommended. No clinically relevant interactions have been reported with oral contraceptives, antacids, or H2-receptor antagonists.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Role in Current Practice&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Despite the challenges of resistance, cefixime remains a useful antibiotic for specific indications where oral therapy is preferred and susceptibility is confirmed. It is valuable in the treatment of uncomplicated UTIs in adults and children, and for respiratory tract infections such as sinusitis, acute otitis media, and pharyngitis. However, its role in gonorrhea has diminished. Cefixime is also used as a step-down therapy after initial intravenous cephalosporins for certain infections. The development of resistance and the availability of alternative agents have narrowed its use, but it remains an important drug in the antimicrobial arsenal.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Conclusion&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Cefixime is a well-established third-generation cephalosporin with a favorable safety profile, convenient oral dosing, and activity against many common pathogens. Its clinical utility has been tempered by rising resistance, especially in N. gonorrhoeae and ESBL-producing Enterobacteriaceae. Nevertheless, it continues to play a role in treating uncomplicated infections in both children and adults. As with all antibiotics, prudent use guided by local susceptibility patterns and antimicrobial stewardship principles is essential to preserve its efficacy for future generations.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>BellaSloane344</name></author>
	</entry>
	<entry>
		<id>https://www.cleauxfees.org/mediawiki/index.php?title=Utilisateur:BellaSloane344&amp;diff=12891</id>
		<title>Utilisateur:BellaSloane344</title>
		<link rel="alternate" type="text/html" href="https://www.cleauxfees.org/mediawiki/index.php?title=Utilisateur:BellaSloane344&amp;diff=12891"/>
		<updated>2026-07-14T12:44:44Z</updated>

		<summary type="html">&lt;p&gt;BellaSloane344 : Page créée avec « Hello, I'm Myrna, a 29 year old from Hepscott, United Kingdom.&amp;lt;br&amp;gt;My hobbies include (but are not limited to) Exhibition Drill, Amateur astronomy and watching Doctor Who.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Here is my website - Cialis 10mg - [http://stefanodevecchi.it/cialis/ stefanodevecchi.it] - »&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Hello, I'm Myrna, a 29 year old from Hepscott, United Kingdom.&amp;lt;br&amp;gt;My hobbies include (but are not limited to) Exhibition Drill, Amateur astronomy and watching Doctor Who.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Here is my website - Cialis 10mg - [http://stefanodevecchi.it/cialis/ stefanodevecchi.it] -&lt;/div&gt;</summary>
		<author><name>BellaSloane344</name></author>
	</entry>
</feed>